NR3C1 and breast cancer: In ER + breast cancer models, different SEGRAM compounds (CORT125134, CORT118335, CORT108297) decreased the occupancy of the ER at several enhancers, and the displacement of ER from chromatin by the liganded GR inhibited E2-induced proliferation [111].